β Cell function in long term NIDDM (Type 2) patients and its relation to treatment

Snehalatha, C. ; Ramachandran, A. ; Mohan, V. ; Timothy, H. ; Viswanathan, M. (1986) β Cell function in long term NIDDM (Type 2) patients and its relation to treatment Hormone and Metabolic Research, 18 (6). pp. 391-394. ISSN 0018-5043

Full text not available from this repository.

Official URL: https://www.thieme-connect.com/ejournals/abstract/...

Related URL: http://dx.doi.org/10.1055/s-2007-1012324

Abstract

Pancreatic β cell function was assessed by estimation of fasting and post prandial plasma C-peptide in 183 non-insulin dependent diabetic patients, who were treated with oral hypoglycaemic drugs, for more than 10 years. One-hundred-and-forty-one patients, continued to respond to oral hypoglycaemic agents (Group I) and in 42 the control was not satisfactory and had to be changed over to insulin (secondary failure, Group II). Significant beta cell reserve (PP CP ≥ 0.6 pmol/ml) was present in 89 out of 183 patients (48%) and 83 (93%) of them responded to oral hypoglycaemic agents. Among the 94 patients with low beta cell reserve, 58 (62%) were on oral hypoglycaemic agents and the other 36 (38%) were on insulin. Of the 42 patients with secondary failure to the oral drugs, 36 (86%) had low C-peptide while 6 (14%) had significant C-peptide values. Secondary failure to oral hypoglycaemic agents can also occur in spite of good β cell reserve. β cell reserve was not correlated either to the duration of diabetes or the age at diagnosis of the patients.

Item Type:Article
Source:Copyright of this article belongs to Thieme Medical Publishers.
Keywords:Non-Insulin Dependent Diabetes; Long-term Diabetes; C-Peptide; Secondary Failure to OHA; Therapeutic Responses; β Cell Reserve
ID Code:80526
Deposited On:01 Feb 2012 09:31
Last Modified:01 Feb 2012 09:31

Repository Staff Only: item control page